双相情感障碍:最近治疗试验的更新

Psychopharm review : timely reports in psychopharmacology and device-based therapies Pub Date : 2011-04-01 DOI:10.1097/01.IDT.0000395192.77327.9e

P. Keck, S. McElroy, J. M. Hawkins

{"title":"双相情感障碍:最近治疗试验的更新","authors":"P. Keck, S. McElroy, J. M. Hawkins","doi":"10.1097/01.IDT.0000395192.77327.9e","DOIUrl":null,"url":null,"abstract":"LEARNING OBJECTIVES After participating in this activity, the psychiatrist should be better able to:Evaluate the potential benefits of asenapine, paliperidone extended release, quetiapine, and ziprasidone in the treatment of bipolar disorder from new clinical trial results.Analyze the strengths and limitations of data regarding trials of tamoxifen, N-acetyl cysteine, and armodafinil in bipolar disorder.Apply the data from these new studies into evidence-based treatment of patients with bipolar disorder.","PeriodicalId":90307,"journal":{"name":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2011-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.IDT.0000395192.77327.9e","citationCount":"0","resultStr":"{\"title\":\"Bipolar Disorder: An Update on Recent Therapeutic Trials\",\"authors\":\"P. Keck, S. McElroy, J. M. Hawkins\",\"doi\":\"10.1097/01.IDT.0000395192.77327.9e\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"LEARNING OBJECTIVES After participating in this activity, the psychiatrist should be better able to:Evaluate the potential benefits of asenapine, paliperidone extended release, quetiapine, and ziprasidone in the treatment of bipolar disorder from new clinical trial results.Analyze the strengths and limitations of data regarding trials of tamoxifen, N-acetyl cysteine, and armodafinil in bipolar disorder.Apply the data from these new studies into evidence-based treatment of patients with bipolar disorder.\",\"PeriodicalId\":90307,\"journal\":{\"name\":\"Psychopharm review : timely reports in psychopharmacology and device-based therapies\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1097/01.IDT.0000395192.77327.9e\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychopharm review : timely reports in psychopharmacology and device-based therapies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.IDT.0000395192.77327.9e\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.IDT.0000395192.77327.9e","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

学习目标:参加本活动后，精神科医生应该能够更好地:从新的临床试验结果中评估阿塞那平、帕利哌酮缓释、喹硫平和齐拉西酮治疗双相情感障碍的潜在益处。分析有关他莫昔芬、n -乙酰半胱氨酸和阿莫达非尼治疗双相情感障碍的试验数据的优势和局限性。将这些新研究的数据应用到双相情感障碍患者的循证治疗中。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Bipolar Disorder: An Update on Recent Therapeutic Trials

LEARNING OBJECTIVES After participating in this activity, the psychiatrist should be better able to:Evaluate the potential benefits of asenapine, paliperidone extended release, quetiapine, and ziprasidone in the treatment of bipolar disorder from new clinical trial results.Analyze the strengths and limitations of data regarding trials of tamoxifen, N-acetyl cysteine, and armodafinil in bipolar disorder.Apply the data from these new studies into evidence-based treatment of patients with bipolar disorder.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Psychopharm review : timely reports in psychopharmacology and device-based therapies

自引率

0.00%

发文量